LicianPro

Vir Biotechnology, Inc. ·

VIR 8-K 2026-10-01

Vir Biotechnology, Inc. (VIR) 8-K dated 2026-10-01 — accession 0001628280-26-064117.

Vir Biotechnology, Inc. (VIR) is a biotechnology company listed on NASDAQ.

Vir Biotechnology, Inc. filed a 8-K on 2026-10-01. Accession 0001628280-26-064117.

This 8-K covers: Director/officer change (Item 5.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported VIR revenue for 2025-12-31 was $68.6M. Net income was -$438.0M. Revenue was down 7.6% from 2024-12-31 to 2025-12-31. VIR currently screens at market cap $1.45B.

Not investment advice. The VIR SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr